Next Investors logo grey

MED Set to Recommence Diamond Production

Published 21-DEC-2017 10:14 A.M.

|

10 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

We’re avoiding all the ‘girl’s-best-friend’ stereotypes, and staying firmly on the trail of a diamond in the rough in this edition of The Next Small Cap .

Merlin Diamonds (ASX:MED) is an ASX-listed sparkler still in its infancy on its way to becoming a dominant diamond producer. However MED can already be credited with Australia’s largest diamond find.

MED, which has assets in the Northern Territory and Western Australia, also wields Australia’s 5 th largest diamond discovery of 35.26cts, extracted in January 2017. Click on the video below , to see MED’s assortment of diamonds extracted:

merlin diamonds

It should be noted here that MED is an early stage play and investors should seek professional financial advice if considering this stock for their portfolio.

Whilst the company has been not in production lately, it is now ready to start production using a Tomra XRT sorter. This means MED could once again manifest high-carat rough diamonds at a consistent rate, outscoring much larger mining operations around the globe.

The Tomra XRT is important as it enables MED to recover large diamonds up to 40mm in size, which wasn’t previously possible for MED given its plant limitations.

Furthermore, a new processing plant will be able to process ore up to 40mm in size compared to the previously used 20mm. It is expected that the new processing technology will also improve diamond recovery efficiencies and costs.

With all that in mind, MED could represent a value-based investment opportunity.

Updating you on:

merlin diamonds asx

Merlin Diamonds (ASX:MED) is a diamond explorer working at the sharp end of diamond commercialisation, and its operations are gathering pace.

MED’s first batch of kimberlite ore is ready for processing, which effectively means the company has 150,000 tons of material it can potentially harness and generate revenue from.

Having commissioned a specialised Tomra X-Ray Transmission (XRT) sorter, MED is now ready to resume production and quickly pick out its next set of rough diamonds (only with a much higher carat-size).

northern territory diamonds

Source: Merlin Diamonds

The important carrot for MED is that it will generate cashflow in coming months as it initiates its longstanding aim of becoming a large-scale diamond miner. MED is effectively using ‘pay-as-you-go’ exploration whereby the proceeds from its current small-scale operation will be reinvested into mining for higher carat stones and higher-grade kimberlite.

In order to stand a chance of reeling in the largest diamonds, MED is turning to Tech

MED recently purchased and Tomra XRT sorter which works more efficiently, more accurately, faster and is more cost effective than conventional equipment.

One of Africa’s largest mines (Karowe) demonstrated how effective Tomra XRT-enabled sorting can be, after it installed multiple XRT sorters to recover larger stones. In 2015, aided by Tomra XRT, Karowe’s operator (Lucara) recovered a 1,111 carat stone, the second biggest in history.

The Tomra XRT sorting process uses the detection of the carbon atomic density of diamond (similar to airport x-ray security systems) to separate diamonds from surrounding waste. This is in contrast to previous traditional x-ray luminescence sorting machines that rely on diamonds to luminescence when exposed to x-rays. However, a proportion of diamonds display low luminescence and may not have been recovered. It is expected that the new processing technology will also improve diamond recovery efficiencies at lower luminescence, compared to past practices that may have not recovered some diamonds with low luminescence.

As a benchmark comparison, Lucara recently sold a 341.9-carat diamond of roughly the same quality for $20.6 million — which equates to around $60,251 per carat.

MED is becoming a bit of a big-ticket item hauler, with its own plump diamond discoveries. The reason why MED now has its hat in the proverbial ring, because the company is now using the same high-calibre equipment as Lucara, otherwise known as the Tomra XRT, and it has a history of big diamonds.

Let’s review MED’s chances to see if this gem-extractor can extract some benchmark premiums for investors.

MED digs up diamond-bearing ore, processes it in a simple low-energy method, and then sell the rough diamond content in Antwerp, Belgium.

The simplified route to market, combined with MED’s low cost-base, gives us confidence that MED will be able to sustain its production rate for many years, and that’s assuming no additional exploration or additions to its existing JORC Resource of 19Mt at 24cpht for 4.31Mcts .

The Location

The Merlin Diamond Project comprises exploration tenements in the Northern Territory which effectively encompasses the known extent of the Merlin kimberlite field.

merlin kimberlite diamond field

The Merlin Diamond Project is located some 100 kilometres south of the settlement of Borroloola and comprises 14 kimberlite pipes, grouped into four clusters. Nine of these pipes were subject to open-pit mining over a five year period commencing in 1998. The operations ceased in 2003 having produced 507,000 carats of diamonds. However, this is where MED has all of Rio Tinto’s oversize material.

The big attraction of MED’s Merlin mine is the fact that it holds the record for the largest diamond ever found in Australia along with a large population of sizable diamonds.

australia's largest diamond

Source: Merlin Diamonds

Here is MED in action:

merlin kimberlite field site

Source: Merlin Diamonds

All the kimberlite rock that MED extracts is processed and sorted for rough diamond nuggets that can then be further refined into high-value gems.

kimberlite field mining equipment

All the excess ore that cannot be processed immediately, is then stockpiled for processing to be carried out at the next available opportunity. Given the fact that MED’s facility is able to run around the clock, even at night-time, reflects the additional processing capacity MED has access to, as well as the simplicity of diamond mining in general.

The bottom line is that processing kimberlite is not energy or chemical intensive. This means far lower safety or environmental risks and is very conducive for strong project viability.

The Merlin kimberlite field was discovered by Ashton Mining Ltd after systematic exploration between 1991 and 1994. After periods of trial mining and feasibility studies Ashton Mining Ltd was taken over by Rio Tinto Pty Ltd.

Merlin did not fit into the asset portfolio of Rio Tinto as it was too small and subsequently the Merlin mine was acquired by North Australian Diamonds Ltd in 2004. Since that time resource definition drilling and trial production increased the known JORC-compliant Resource of diamonds to be the second largest in Australia, surpassed only by the Argyle diamond mine.

Under the leadership of Joseph Gutnick ( who recently boosted his stock holding in MED ), feasibility studies examining options to enable near term production at Merlin were commissioned. As a result of these studies, the company applied for and was granted a MMP (mining management plan) which enabled it to recommence diamond production in 2013.

During its short operational life, the Merlin Diamond Project was renowned for the production of top quality white diamond and large specials. In 2012, a parcel sourced from Merlin was sold on international markets generating proceeds of US$1.865 million.

However it is an early stage of this company’s development and if considering this stock for your portfolio you should take all public information into account and seek professional financial advice.

Let’s take a look at what MED has hauled in so far

As we’ve said already, MED is placed in amidst some of best kimberlite deposits in the world.

In addition to the most highly-prized crystal-clear diamonds, shown below...

crystal clear diamond northern territory

...MED is also proving up coloured diamond derivatives which indicate a high-value project with plenty of diversity in the type of colouration.

Next Investors Image

Source: Merlin Diamonds

As you can see, MED is birthing surprisingly large diamonds in the rough, on a regular basis, and it’s all down to the geology and equipment.

In the most recent sale, MED achieved a price of US$11,897 per carat for a total revenue of US$157,880 which bodes well for future production.

Let’s see what kind of officially-recognised assets MED has so far...

First of all, here is MED’s all-encompassing ‘ore reserve’ which boasts 11.1Mt at 26cpht and 2.89Mcts (million carats).

Merlin ore reserve

From that, MED’s JORC Resource can then be whittled down to a more accurate, commercialisation-friendly number.

From the various Kimberlitic volcanic pipes in MED’s possession, MED is estimated to have an Inferred Mineral Resource of 15.93Mt and an Indicated Resource of 3.1Mt. In total, MED’s diamond project in the Northern Territory is estimated to contain 19.02Mt at 24cpht for 4.31Mcts.

inferred mineral resource merlin

For a company worth A$13 million and priced at 0.6 cents per share, a JORC Resource stretching into the millions of tonnes suggests there is revaluation ahead.

The future performance of this product should not be assumed based upon current or past performance alone. Caution should be exercised in assessing future claims of performance, as these are based on assumptions and structured guesses. This product, like all other financial products, is subject to market forces and unpredictable events that may adversely affect future performance.

Also ahead, is the prospect of MED conducting further exploration and adding to its Indicated Resource next year.

Diamond Industry sparkling in wait

The world diamond market is represented by diamond mining and trade in rough diamonds. The bulk of the world diamond mining is concentrated in nine countries, with their share in the global production in physical terms as high as 99%. The world’s largest producers of natural diamonds are Russia, Botswana and the Democratic Republic of Congo (DRC), all together accounting for 59% of the global diamond production.

However, Australia is gradually crawling up the list of global diamond producers. The name of the game in diamonds, is pretty much the same as in all other resources exploration projects: cost.

diamond industry by country

MED’s relatively low cost-structure, already proven from existing production, combined with the outstanding high-carat discoveries it has delivered indicates that MED will be a competitive diamond producer over time, potentially able to compete with gargantuan producers from Russia and Europe.

Overall this is an early stage play and as such any investment decision should be made with caution and professional financial advice should be sought.

Looking for friends in the world of diamonds

With so much opportunistic potential now coming back onto the table in the world of commodities, adding this sturdy diamond producer to your investment portfolio could be diversification-inducing, as well as lucrative.

MED’s inspired decision to upgrade its processing capabilities via XRT, provides an exciting opportunity for MED to recover diamonds that are larger than previously recovered in a cost-effective manner.

We’re not scouring for ready-made sparklers with a bit of polish and sheen. Instead, we’re looking intently at here at a diamond in the rough, which will hopefully become a polished ASX jewel in the years to come.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.